EPIC Trademark

Trademark Overview


On Friday, October 21, 2022, a trademark application was filed for EPIC with the United States Patent and Trademark Office. The USPTO has given the EPIC trademark a serial number of 97642362. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Monday, December 9, 2024. This trademark is owned by invIOs GmbH. The EPIC trademark is filed in the Treatment & Processing of Materials Services, Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Contract manufacturing of therapeutic medicinal products, namely, Contract manufacturing of cell therapies for the treatment of inflammatory diseases, diseases of the immune system and cancer; Contract manufacturing for others, in particular manufacturing of pharmaceutical preparations for health care, for the treatment of people suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicinal products for human use including investigational medicinal products, investigational biological products, cell therapy preparations and advanced therapy medicinal products, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling

Chemical, biological and biochemical preparations and reagents for the cultivation of human immune cells, in particular T cells, for medical purposes in the treatment of immuno-oncological diseases; Human immune cells, in particular T cells, for medical or clinical purposes; biological preparations and pharmaceutical compositions containing human immune cells, in particular T cells for the treatment of immuno-oncological diseases; biological preparations and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T cell therapy; biological preparations and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biologi...

Human immune cells, in particular T cells, for scientific and medical research

Medical services related to the treatment and preparation of human cells; medical services, namely, immune cell therapy; medical services, namely, immune cell modification; medical services, namely, administration of immune cells; medical consulting related to immune cell therapy, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling

Development of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling

General Information


Serial Number97642362
Word MarkEPIC
Filing DateFriday, October 21, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateMonday, December 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesContract manufacturing of therapeutic medicinal products, namely, Contract manufacturing of cell therapies for the treatment of inflammatory diseases, diseases of the immune system and cancer; Contract manufacturing for others, in particular manufacturing of pharmaceutical preparations for health care, for the treatment of people suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicinal products for human use including investigational medicinal products, investigational biological products, cell therapy preparations and advanced therapy medicinal products, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
Goods and ServicesChemical, biological and biochemical preparations and reagents for the cultivation of human immune cells, in particular T cells, for medical purposes in the treatment of immuno-oncological diseases; Human immune cells, in particular T cells, for medical or clinical purposes; biological preparations and pharmaceutical compositions containing human immune cells, in particular T cells for the treatment of immuno-oncological diseases; biological preparations and pharmaceutical preparations for use in medical and clinical cell therapy, in particular immune cell therapy, in particular T cell therapy; biological preparations and pharmaceutical composition containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations containing human immune cells, in particular T-cells, for the treatment of inflammatory diseases, diseases of the immune system and cancer; biological preparations and pharmaceutical preparations in the form of living cells for use in the treatment of immuno-oncological diseases
Goods and ServicesHuman immune cells, in particular T cells, for scientific and medical research
Goods and ServicesMedical services related to the treatment and preparation of human cells; medical services, namely, immune cell therapy; medical services, namely, immune cell modification; medical services, namely, administration of immune cells; medical consulting related to immune cell therapy, all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling
Goods and ServicesDevelopment of biological and pharmaceutical medicinal products for the treatment of diseases using a cell therapy platform; all of the foregoing not in connection with medical diagnostics, cancer diagnostics and cancer profiling

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, May 18, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateSunday, November 6, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, November 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, November 6, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameinvIOs GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressWien 1030
AT

Party NameinvIOs GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWien 1030
AT

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2022NEW APPLICATION ENTERED
Sunday, November 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 8, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, January 5, 2023ASSIGNED TO LIE
Friday, January 6, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, March 31, 2023ASSIGNED TO EXAMINER
Monday, April 10, 2023NON-FINAL ACTION WRITTEN
Monday, April 10, 2023NON-FINAL ACTION E-MAILED
Monday, April 10, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 18, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, May 18, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, May 18, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 18, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, May 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 23, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, June 30, 2023ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, July 19, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 8, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 8, 2023NOTICE OF ALLOWANCE CANCELLED
Wednesday, November 8, 2023CASE RETURNED TO EXAMINATION
Wednesday, November 29, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Wednesday, November 29, 2023SUSPENSION LETTER WRITTEN
Wednesday, November 29, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, November 29, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 15, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOTICE OF ALLOWANCE CANCELLED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 9, 2024REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED
Monday, December 9, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 9, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 9, 20241(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 7, 2024TEAS DELETE 1(B) BASIS RECEIVED